A Study to Evaluate the Safety and Efficacy of ATHENA CAR-T in Subjects With Systemic Lupus Erythematosus
Conditions: Lupus Erythematosus, Systemic Interventions: Biological: ATHENA CAR-T; Drug: Fludarabine; Drug: Cyclophosphamide Sponsors: EdiGene Inc.; The First Affiliated Hospital of Henan University of Science and Technology; Changping Laboratory Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 18, 2024 Category: Research Source Type: clinical trials
Study of Injectable Naltrexone and Oral Bupropion Among Cigarette Smokers With Schizophrenia
Conditions: Smoking Cessation Interventions: Drug: Naltrexone (Vivitrol); Drug: Bupropion Sponsors: The University of Texas Health Science Center, Houston Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 18, 2024 Category: Research Source Type: clinical trials
Relative Energy Deficiency in Sports (REDs) in Swedish Athletes
Conditions: RED S; Eating Disorders Sponsors: Linnaeus University; Swedish Olympic Committee; Swedish Research Council for Sport Science; World Anti-Doping Agency Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 17, 2024 Category: Research Source Type: clinical trials
IDEAL SKIIN CARES Bundle to Prevent Pressure Injury
Conditions: Pressure Ulcer; Pressure Injury; Bed Sore; Pressure Sore; Decubitus Sore; Decubitus Ulcer; Skin Ulcer Interventions: Other: IDEAL SKIIN CARES bundles; Other: IDEAL SKIIN CARES bundles workshop; Other: Respiratory care workshop Sponsors: Baqiyatallah Medical Sciences University; Tehran University of Medical Sciences; Hamadan University of Medical Science; Tabriz University of Medical Sciences Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 17, 2024 Category: Research Source Type: clinical trials
Investigating Two Prototype Mobile App Interventions to Increase Physical Activity
Conditions: Health-Related Behavior Interventions: Behavioral: Values Clarification Mobile Application; Behavioral: Self-Reflection Mobile Application Sponsors: Mississippi State University; Association for contextual behavioral science Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 17, 2024 Category: Research Source Type: clinical trials
The Prediction Model of NAC Response for Breast Cancer Based on The Parametric Dynamics Features.
Conditions: Breast Cancer; Chemotherapy Effect; Diffusion Weighted MRI; PET Imaging; Multiparametric Magnetic Resonance Imaging Interventions: Radiation: Whole body 18F-FDG Positron Emission Tomography Sponsors: National Taiwan University Hospital; Ministry of Science and Technology, Taiwan Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 17, 2024 Category: Research Source Type: clinical trials
The Study of Huaier Granule in Postoperative Adjuvant Therapy of Resectable Pancreatic Cancer
Conditions: Pancreatic Cancer Resectable Interventions: Drug: Huaier granule; Drug: chemotherapy drugs Sponsors: Health Science Center of Xi ' an Jiaotong University; LinkDoc Technology (Beijing) Co. Ltd.; Huazhong University of Science and Technology Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 16, 2024 Category: Research Source Type: clinical trials
Long Term Impact of Child Abuse in University Students
Conditions: Child Abuse Sponsors: Delta University for Science and Technology Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 15, 2024 Category: Research Source Type: clinical trials
Implementation of Two Transdiagnostic Interventions Based on Emotional Regulation (DBT and UP) for Alcohol Addiction
Conditions: Implementation Science Interventions: Behavioral: Dialectical Behavior Therapy for Substance Use Disorder (DBT-SUD); Behavioral: Unified Protocol (UP) Sponsors: Universidad de Zaragoza; Ministerio de Sanidad, Servicios Sociales e Igualdad Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 15, 2024 Category: Research Source Type: clinical trials
An Early Warning Model of Unfavorable Outcomes Following Endovascular Interventional Treatment of Intracranial Aneurysm
Conditions: Intracranial Aneurysm Interventions: Other: Observational design does not include interventional behavior. Sponsors: Beijing Tiantan Hospital; National Natural Science Foundation of China Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 15, 2024 Category: Research Source Type: clinical trials
Safety and Preliminary Efficacy of Allogeneic Endothelial Progenitor Cells (EPCs) in Patients With Critical Limb Ischemia
Conditions: Critical Limb Ischemia Interventions: Drug: EPCs; Behavioral: Clinical standard treatment (CST) Sponsors: Allife Medical Science and Technology Co., Ltd.; First Affiliated Hospital Xi ' an Jiaotong University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 11, 2024 Category: Research Source Type: clinical trials
Effect of Percutaneous Acupoint Electrical Stimulation on Delirium
Conditions: Delirium, Postoperative Interventions: Device: Transcutaneous Electrical Acupoint Stimulation Sponsors: Qin Zhang; National Natural Science Foundation of China Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 11, 2024 Category: Research Source Type: clinical trials
The Impacts of Mindfulness on Psychological Wellbeing Among Nursing Students
Conditions: Students Interventions: Other: mindfulness course Sponsors: Chang Gung University of Science and Technology Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 11, 2024 Category: Research Source Type: clinical trials
Iadademstat in Combination With Azacitidine and Venetoclax in Treating Newly Diagnosed Acute Myeloid Leukemia
Conditions: Acute Myeloid Leukemia; Myelodysplastic Syndrome/Acute Myeloid Leukemia Interventions: Drug: Azacitidine; Procedure: Biospecimen Collection; Procedure: Bone Marrow Biopsy; Procedure: Echocardiography; Drug: Iadademstat; Procedure: Multigated Acquisition Scan; Other: Questionnaire Administration; Drug: Venetoclax Sponsors: OHSU Knight Cancer Institute; Oregon Health and Science University; Oryzon Genomics S.A. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 10, 2024 Category: Research Source Type: clinical trials
Glofitamab Plus Ibrutinib With Obinutuzumab for the Treatment of Patients With Mantle Cell Lymphoma
Conditions: Mantle Cell Lymphoma Interventions: Procedure: Biospecimen Collection; Procedure: Bone Marrow Biopsy; Procedure: Computed Tomography; Procedure: Echocardiography; Procedure: FDG-Positron Emission Tomography; Biological: Glofitamab; Drug: Ibrutinib; Procedure: Magnetic Resonance Imaging; Biological: Obinutuzumab Sponsors: OHSU Knight Cancer Institute; Oregon Health and Science University; Genentech, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 10, 2024 Category: Research Source Type: clinical trials
